In contrast, GH treatment in the transition period and in adults with PWS without prior GH stimulation testing is only approved in a few countries (The Netherlands and Poland), and in most countries reassessment of GH secretion must be performed and results evaluated according to guidelines for the diagnosis of GH deficiency in adults (28). Here, GH1 is linked to Prader-Willi syndrome.